20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Securing Your Antiretroviral Drug Precursor Supply Chain with 173676-59-0

In the complex world of pharmaceutical manufacturing, especially for life-saving antiretroviral drugs, a robust and dependable supply chain is not merely an advantage—it's a necessity. The consistent availability of high-quality precursors, such as 4-Chloro-2-(trifluoroacetyl)aniline hydrochloride (CAS: 173676-59-0), is paramount for the uninterrupted production of medications like Efavirenz. Delays or quality compromises in sourcing can have far-reaching implications, impacting patient access and treatment efficacy.


NINGBO INNO PHARMCHEM CO.,LTD. understands these critical demands. As a dedicated manufacturer and supplier of this essential Efavirenz intermediate, we prioritize the integrity and efficiency of your antiretroviral drug precursor supply chain. We ensure that our 4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is produced with an unwavering commitment to high purity, minimizing the risks associated with raw material variability. When you choose to buy 4-chloro-2-(trifluoroacetyl)aniline hydrochloride from us, you are investing in a partnership that guarantees consistent quality and supply.


Our operational excellence is designed to support global pharmaceutical demands, offering competitive 4-chloro-2-(trifluoroacetyl)aniline hydrochloride price without compromising on product specifications. This allows pharmaceutical companies to maintain cost-effectiveness while adhering to the highest standards of drug safety and efficacy. By focusing on a reliable supply of key pharmaceutical raw material Efavirenz precursors, NINGBO INNO PHARMCHEM CO.,LTD. helps you mitigate supply chain risks and enhance your production stability.


Furthermore, our rigorous quality control processes ensure that every batch of this crucial compound meets international pharmaceutical standards. For those looking to purchase 4-chloro-2-trifluoroacetyl-aniline-hydrochloride, our established infrastructure and expertise provide peace of mind, knowing that a vital component for HIV-1 RT inhibitor production is always within reach. Strengthen your supply chain with a trusted partner committed to quality and reliability in antiretroviral drug manufacturing.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Human Ghrelin: A Catalyst for Peptide Therapeutics and Research Innovation

Next: The Role of High-Purity Pharmaceutical Intermediates in HIV Treatment

All Rights Reserved